General
Preferred name
DIOSMIN
Synonyms
Venosmine ()
Diosmil ()
Barosmin ()
Diosmin ()
Ven-detrex ()
Diosmina ()
Diovenor ()
Flebaven ()
Varinon ()
Dioven ()
Flebosten ()
HESPERIDIN ()
Hemerven ()
Tovene ()
Buchu resin ()
Diosven ()
Insuven ()
Flebavena ()
Litosmil ()
NSC-758417 ()
Flebosmil ()
Diosmine ()
Diosmetin 7-rutinoside ()
Daflon ()
P&D ID
PD001043
CAS
520-27-4
111804-73-0
Tags
available
drug
Drug Status
approved
withdrawn
investigational
Max Phase
4.0
Drug indication
Infertility
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
29
DESCRIPTION
Diosmin (Venosmine) is a bioflavonoid that strengthens vascular walls.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
0
Compound Sets
17
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
Mcule NIBR MoA Box Subset
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
39
Molecular Weight
608.17
Hydrogen Bond Acceptors
15
Hydrogen Bond Donors
8
Rotatable Bonds
7
Ring Count
5
Aromatic Ring Count
3
cLogP
-1.09
TPSA
238.2
Fraction CSP3
0.46
Chiral centers
10.0
Largest ring
6.0
QED
0.16
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
MOA
Norepinephrine
Aryl Hydrocarbon Receptor (AhR) Agonists
aryl hydrocarbon receptor agonist, capillary stabilizing agent
Member status
member
Indication
chronic venous insufficiency (CVI), edema, deep vein thrombosis (DVT), statis dermatitis, heavy leg syndrome
Disease Area
cardiology, hematology, dermatology
Target
AHR
Aryl hydrocarbon receptor
Norepinephrine (NE)
Pathway
Immunology/Inflammation
Neuroscience
Source data

